Assembly Biosciences, Inc. (ASMB) vs Evolus, Inc. (EOLS)
A side-by-side comparison of Assembly Biosciences, Inc. and Evolus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.17HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
EOLS
Evolus, Inc.
$7.36HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ASMB vs EOLS
growth of $100 · dividends reinvested · last 9yASMB -95.8% (-29.7%/yr)EOLS -35.0% (-4.7%/yr)EOLS compounded faster over this window
Log scale — wide-divergence pair
ASMB EOLS
ASMB vs EOLS: by the numbers
- •EOLS is the larger company ($485M vs $439M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -10.85% net margin).
- •EOLS grew revenue faster over the past five years (32.82% vs -1.78% CAGR).
Metrics side by side
Valuation
| Metric | ASMB | EOLS |
|---|---|---|
| P/E ratio | 40.30 | N/A |
| P/S ratio | 5.87 | 1.53 |
| P/B ratio | 1.44 | N/A |
Profitability
| Metric | ASMB | EOLS |
|---|---|---|
| Gross margin | 99.82% | 66.25% |
| Operating margin | -11.75% | -7.33% |
| Net margin | -0.06% | -10.85% |
| ROE | -0.01% | N/A |
| ROIC | -2.86% | -15.54% |
Growth (annualized)
| Metric | ASMB | EOLS |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | 32.82% |
| Total return CAGR (5Y) | -10.66% | 0.46% |
Frequently asked
- Which has grown faster, ASMB or EOLS?
- Over the past five years, EOLS grew revenue faster — ASMB at a -1.78% CAGR versus EOLS at 32.82%.
- How have ASMB and EOLS total returns compared?
- Over the past 5 years, ASMB delivered -10.66% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioAssembly Biosciences ROEEvolus ROEAssembly Biosciences operating marginEvolus operating marginAssembly Biosciences revenue growthEvolus revenue growthAssembly Biosciences free cash flowEvolus free cash flow
Assembly Biosciences & Evolus appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.